about
Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B.Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesUtilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugsIn Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial AgentsImportance of microbial natural products and the need to revitalize their discovery.Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitorsSynthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinaminesNovel approach to mapping of resistance mutations in whole genomes by using restriction enzyme modulation of transformation efficiencyInternal loop photobiodegradation reactor (ILPBR) for accelerated degradation of sulfamethoxazole (SMX).The relationship among antibiotic consumption, socioeconomic factors and climatic conditions.The evolving role of chemical synthesis in antibacterial drug discovery.Are natural products still the best source for antibacterial discovery? The bacterial entry factor.The determinants of the antibiotic resistance process.Commentary: Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenalEfflux-mediated antimicrobial resistance.Stopping bacterial adhesion: a novel approach to treating infections.Pharmacoeconomics of treatment with the newer anti-Gram-positive agents.Innovative lead discovery strategies for tropical diseases.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Recent advances in the chemistry and biology of naturally occurring antibiotics.Bench-to-bedside review: Bacterial virulence and subversion of host defences.Microbial drug discovery: 80 years of progress.Total synthesis of platensimycin and related natural productsPeptide design for antimicrobial and immunomodulatory applications.Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity.Development of novel drugs from marine surface associated microorganisms.Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.Metabolic network modeling and simulation for drug targeting and discovery.Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.Computational methods to identify new antibacterial targets.Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans.Antimicrobial peptides of the genus Bacillus: a new era for antibiotics.In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.Expansion of Antibacterial Spectrum of Muraymycins toward Pseudomonas aeruginosa.Evaluation of preparation methods for MS-based analysis of intestinal epithelial cell proteomes.Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes.Bioactive metabolites of Diaporthe sp. P133, an endophytic fungus isolated from Pandanus amaryllifolius.Isolation and partial characterization of bacteria (Pseudoalteromonas sp.) with potential antibacterial activity from a marine costal environment from New Caledonia.
P2860
Q21146447-BE75E4FF-81FD-44D6-B035-E4C3188D19F9Q26861137-D30D37EB-9C23-4F68-A120-1F807A4D18CEQ28537776-90BC743E-96E1-40B3-B4A6-9AD41D742255Q28553205-B67E9A5C-6FBA-41CC-B9FE-2C0F727A9A61Q31128037-F6731239-9132-493F-9EE3-8395B87AB515Q33339829-74041419-A194-4A35-8C80-3738841456AEQ33712171-108394CA-90E7-4F25-BBCA-34665D4AB5A0Q33883654-74499F7F-48C9-4113-BDD2-AE5C082B8D84Q34116593-DFFFE424-7384-44FE-B43D-F5FFDDF9DF99Q34184511-6413F392-C77D-4AFD-ABD8-E0C167432176Q34427652-073A9B98-15D9-43CD-8191-8D7E02D2EE52Q34619268-17E94F04-A3AA-4D92-A5A6-943FA6E105BBQ35026542-8AA0805F-AC85-4054-92F2-75E2C82A9342Q35856285-DF925277-A8D2-43F1-865A-2C42C7BD6E88Q36138147-53D1D9C2-94FB-4A69-8647-016E797DBD27Q36222763-A51FE074-6B38-47FF-B9EA-79701777B0B9Q36458452-44E3FBF2-C1F2-40CD-976A-10DB0AB2575CQ36642049-0FFF20EB-0087-4C8E-93F4-A1189CC6EC0DQ36676044-7F48B793-9891-409E-BC59-46CF5DD53972Q37313939-6A0BAEB0-5DD8-4059-B469-349F85D5F069Q37327589-01D15019-DCFD-4409-AEEB-0E6B21AD87CEQ37365189-CAB94EC2-D478-4317-A7E6-0736FEE65114Q37440084-4A7E33F5-6D43-4E2D-9D47-64DC94E8614BQ37598400-229B1261-2975-494C-B107-C044878B81C5Q37701333-B4E385CA-5A0E-4CFC-B89B-2FE5E0EDCA49Q37735703-488ED707-357D-48AB-8003-016CBDBA7765Q37857710-D596DE55-5223-4CA3-B3CE-7FA15F59BF93Q37962486-D83883C8-B0B0-443C-9A20-78C702B0775DQ38009935-8EA0CFDE-9C0D-43CA-943E-B59E4EC92A6CQ38014580-16B6DEF0-8F37-41C7-AFCA-4400B7C73ADFQ38224191-31ED3B73-9973-4F1E-857E-41F7DDEEE914Q38323210-0FA860C2-B143-495A-8987-3DD839EEDEDFQ38335550-6085C0B9-1D6C-4AA4-9528-9542C9F5998BQ39119164-306AA7BB-FA5C-473F-83DC-4D0381B2112AQ39159406-2220EC1B-F862-4F0F-B321-24F65E55B06BQ39781380-F0356261-EC57-472C-88BB-8A59D4DB0630Q41234808-6C286752-71AD-40D3-A9AB-C1EA83501D7CQ41823699-E98D4982-8FC8-4DA2-A0C0-2EA051927BC8Q42746420-4FC10E17-FB90-457C-9CD3-858FC35C8AD0Q46985436-87A57891-6E48-46D3-B134-6F48708FFC2E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antibiotics: where did we go wrong?
@ast
Antibiotics: where did we go wrong?
@en
type
label
Antibiotics: where did we go wrong?
@ast
Antibiotics: where did we go wrong?
@en
prefLabel
Antibiotics: where did we go wrong?
@ast
Antibiotics: where did we go wrong?
@en
P1433
P1476
Antibiotics: where did we go wrong?
@en
P2093
John F Barrett
Karen M Overbye
P356
10.1016/S1359-6446(04)03285-4
P577
2005-01-01T00:00:00Z